Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials
Authors
Keywords
-
Journal
CANCER
Volume 125, Issue 2, Pages 307-316
Publisher
Wiley
Online
2018-10-18
DOI
10.1002/cncr.31784
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†
- (2018) F Cardoso et al. ANNALS OF ONCOLOGY
- Pregnancy Outcomes After a Breast Cancer Diagnosis: A Systematic Review and Meta-analysis
- (2018) Brigitte Gerstl et al. Clinical Breast Cancer
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update
- (2018) Neelima Denduluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update
- (2018) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients
- (2018) Jorine de Haan et al. LANCET ONCOLOGY
- The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients
- (2018) Matteo Lambertini et al. BREAST
- Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status
- (2017) Matteo Lambertini et al. JNCI-Journal of the National Cancer Institute
- Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status
- (2017) Matteo Lambertini et al. JNCI-Journal of the National Cancer Institute
- The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis
- (2016) Emily K. Hartman et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients
- (2016) Matteo Lambertini et al. BRITISH JOURNAL OF CANCER
- Dual Block with Lapatinib and Trastuzumab Versus Single-Agent Trastuzumab Combined with Chemotherapy as Neoadjuvant Treatment of HER2-Positive Breast Cancer: A Meta-analysis of Randomized Trials
- (2016) M. Clavarezza et al. CLINICAL CANCER RESEARCH
- Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
- (2016) Martine Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted agents for cancer treatment during pregnancy
- (2015) Matteo Lambertini et al. CANCER TREATMENT REVIEWS
- Exploring the safety of chemotherapy for treating breast cancer during pregnancy
- (2015) Matteo Lambertini et al. Expert Opinion On Drug Safety
- Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy
- (2015) Frédéric Amant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Diagnosed During Pregnancy
- (2015) Sibylle Loibl et al. JAMA Oncology
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
- (2014) Evandro de Azambuja et al. LANCET ONCOLOGY
- Maternal Prepregnancy Folate Intake and Risk of Spontaneous Abortion and Stillbirth
- (2014) Audrey J. Gaskins et al. OBSTETRICS AND GYNECOLOGY
- Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) F. A. Peccatori et al. ANNALS OF ONCOLOGY
- Challenges of Guarantee-Time Bias
- (2013) Anita Giobbie-Hurder et al. JOURNAL OF CLINICAL ONCOLOGY
- Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98
- (2013) Elżbieta Senkus et al. PSYCHO-ONCOLOGY
- Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01)
- (2012) Hatem A. Azim et al. BREAST CANCER RESEARCH AND TREATMENT
- Trastuzumab administration during pregnancy: a systematic review and meta-analysis
- (2012) Flora Zagouri et al. BREAST CANCER RESEARCH AND TREATMENT
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer
- (2011) Joseph M. Letourneau et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started